[Clinical study of injectable sermion in otologic diseases].
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006311:Hearing Disorders / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D007759:Labyrinth Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009530:Nicergoline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014717:Vertigo / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D009530:Nicergoline
Etude clinique du sermion injectable en pathologie otologique.